ALKERMES reported $1.94B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Acorda Therapeutics ACOR:US USD 393.34M 12.97M
Amgen AMGN:US USD 63.7B 4.41B
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Coherus Biosciences CHRS:US USD 550.91M 4.9M
Eli Lilly And LLY:US USD 47.46B 397.9M
Gilead Sciences GILD:US USD 62.56B 313M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Horizon Pharma HZNP:US USD 9.03B 174.39M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Marinus Pharmaceuticals MRNS:US USD 184.84M 75.46M
Minerva Neurosciences NERV:US USD 59.76M 5.2M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Otsuka Holdings 4578:JP JPY 3.19T 86.46B
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Revance Therapeutics RVNC:US USD 711.59M 149.71M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B